Compare Gema Grahasarana Tbk. (GEMA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gema Grahasarana Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Gema Grahasarana Tbk. trades at Rp93 (market cap 148.8B, 3.37M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 83.1× Gema Grahasarana Tbk.'s market cap, and Gema Grahasarana Tbk. is more actively traded (3.37M versus 1.41M). Which is the better fit depends on your goals.
| GEMA | TSPC | |
|---|---|---|
Market Cap | 148.8B | 12.36T |
Volume | 3.37M | 1.41M |
Lot | 33.71K | 14.08K |
Turnover | 308.17M | 3.83B |
Average Price | 91.43 | 2,722.04 |
Value | 308.17M | 3.83B |
Indicative Equilibrium Price | 93 | 2,730 |
Indicative Equilibrium Volume | 2 | 2.51K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gema Grahasarana Tbk.
PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
